Cargando…
Cancer immunity and immunotherapy beyond COVID-19
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061391/ https://www.ncbi.nlm.nih.gov/pubmed/36995489 http://dx.doi.org/10.1007/s00262-023-03411-9 |
| _version_ | 1785017279863324672 |
|---|---|
| author | Bellone, Matteo Brevi, Arianna Bronte, Vincenzo Dusi, Silvia Ferrucci, Pier Francesco Nisticò, Paola Rosato, Antonio Russo, Vincenzo Sica, Antonio Toietta, Gabriele Colombo, Mario Paolo |
| author_facet | Bellone, Matteo Brevi, Arianna Bronte, Vincenzo Dusi, Silvia Ferrucci, Pier Francesco Nisticò, Paola Rosato, Antonio Russo, Vincenzo Sica, Antonio Toietta, Gabriele Colombo, Mario Paolo |
| author_sort | Bellone, Matteo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10061391 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100613912023-03-30 Cancer immunity and immunotherapy beyond COVID-19 Bellone, Matteo Brevi, Arianna Bronte, Vincenzo Dusi, Silvia Ferrucci, Pier Francesco Nisticò, Paola Rosato, Antonio Russo, Vincenzo Sica, Antonio Toietta, Gabriele Colombo, Mario Paolo Cancer Immunol Immunother Meeting Report Springer Berlin Heidelberg 2023-03-30 2023 /pmc/articles/PMC10061391/ /pubmed/36995489 http://dx.doi.org/10.1007/s00262-023-03411-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Meeting Report Bellone, Matteo Brevi, Arianna Bronte, Vincenzo Dusi, Silvia Ferrucci, Pier Francesco Nisticò, Paola Rosato, Antonio Russo, Vincenzo Sica, Antonio Toietta, Gabriele Colombo, Mario Paolo Cancer immunity and immunotherapy beyond COVID-19 |
| title | Cancer immunity and immunotherapy beyond COVID-19 |
| title_full | Cancer immunity and immunotherapy beyond COVID-19 |
| title_fullStr | Cancer immunity and immunotherapy beyond COVID-19 |
| title_full_unstemmed | Cancer immunity and immunotherapy beyond COVID-19 |
| title_short | Cancer immunity and immunotherapy beyond COVID-19 |
| title_sort | cancer immunity and immunotherapy beyond covid-19 |
| topic | Meeting Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061391/ https://www.ncbi.nlm.nih.gov/pubmed/36995489 http://dx.doi.org/10.1007/s00262-023-03411-9 |
| work_keys_str_mv | AT bellonematteo cancerimmunityandimmunotherapybeyondcovid19 AT breviarianna cancerimmunityandimmunotherapybeyondcovid19 AT brontevincenzo cancerimmunityandimmunotherapybeyondcovid19 AT dusisilvia cancerimmunityandimmunotherapybeyondcovid19 AT ferruccipierfrancesco cancerimmunityandimmunotherapybeyondcovid19 AT nisticopaola cancerimmunityandimmunotherapybeyondcovid19 AT rosatoantonio cancerimmunityandimmunotherapybeyondcovid19 AT russovincenzo cancerimmunityandimmunotherapybeyondcovid19 AT sicaantonio cancerimmunityandimmunotherapybeyondcovid19 AT toiettagabriele cancerimmunityandimmunotherapybeyondcovid19 AT colombomariopaolo cancerimmunityandimmunotherapybeyondcovid19 |